Dinoprostone Compared With Misoprostol for Cervical Ripening for Induction of Labor at Term

Journal of Midwifery and Women's Health

Volumn 54, Issue 5, 2009, Pages 405-411

  Church, Sara ^a   Van Meter, Auben ^a   Whitfield, Rachael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; OXYGEN; OXYTOCIN; PROSTAGLANDIN E2; TERBUTALINE;

ADULT; APGAR SCORE; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GESTATION PERIOD; HOSPITAL ADMISSION; HUMAN; INFORMED CONSENT; LABOR INDUCTION; LABOR ONSET; MEMBRANE RUPTURE; MIDWIFE; PLACENTAL DELIVERY; PRIORITY JOURNAL; TACHYCARDIA; UTERINE CERVIX DILATATION; UTERINE CERVIX RIPENING; UTERUS CONTRACTION; VAGINAL DELIVERY;

ADULT; CERVICAL RIPENING; CERVIX UTERI; DINOPROSTONE; FEMALE; HUMANS; LABOR, INDUCED; MISOPROSTOL; OXYTOCICS; PREGNANCY; PREGNANCY OUTCOME;

EID: 69249111760     PISSN: 15269523     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmwh.2009.03.006     Document Type: Article

References (25)

1. American College of Obstetricians and Gynecologists. Induction of labor. Practice bulletin 10 (1999), American College of Obstetricians and Gynecologists, Washington, DC
2. Martin J.A., Hamilton B.E., Sutton P.D., Ventura S.J., Menacker F., Kirmeyer S., et al. Births: Final data for 2006 (2009), National Center for Health Statistics, Hyattsville, MD
3. Rath W. A clinical evaluation of controlled-release dinoprostone for cervical ripening-A review of current evidence in hospital and outpatient settings. J Perinat Med 33 (2005) 491-499
4. Kelly A.J., Kavanagh J., and Thomas J. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database Syst Rev 2 (2001) CD003101
5. Tang O.S., Gemzell-Danielsson K., and Ho P.C. Misoprostol: Pharmokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet 99 Suppl 2 (2007) S160-S167
6. Keirse M.J. Natural prostaglandins for induction of labor and preinduction cervical ripening. Clin Obstet Gynecol 49 (2006) 609-626
7. Hofmeyr G., and Gülmezoglu A. Vaginal misoprostol for cervical ripening and induction of labor. Cochrane Database Syst Rev 1 (2003) CD000941
8. Wing D.A., and Gaffaney C.A. Vaginal misoprostol administration for cervical ripening and labor induction. Clin Obstet Gynecol 49 (2006) 627-641
9. ACOG committee opinion. Monitoring during induction of labor with dinoprostone. Number 209, October 1998. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 64 (1999) 200
10. Wood C.L. Complications of gestational ages assessment and the postdate pregnancy. In: Varney H., Kriebs J.M., and Gegor C.L. (Eds). Varney's midwifery. 4th ed (2004), Jones and Bartlett, Boston 723-727
11. American College of Obstetricians and Gynecologists. Vaginal birth after previous cesarean delivery. Practice Bulletin 54 (2004), American College of Obstetricians and Gynecologists, Washington, DC
12. American College of Obstetricians and Gynecologists. New U.S. Food and Drug Administration labeling on Cytotec (Misoprostol) use and pregnancy. Committee Opinion 283 (1999), American College of Obstetricians and Gynecologists, Washington, DC
13. Goldberg A.B., and Wing D.A. Induction of labor: The misoprostol controversy. J Midwifery Womens Health 48 (2003) 244-248
14. Weeks A., Alfirevic Z., Faúndes A., Hofmeyer G.J., Safar P., and Wing D. Misoprostol for induction of labor with a live fetus. Int J Gynaecol Obstet 99 Suppl 2 (2007) S194-S197
15. Wing D.A., Lovett K., and Paul R.H. Disruption of prior uterine incision following misoprostol for labor induction in women with previous cesarean delivery. Obstet Gynecol 91 5 Part 2 (1998) 828-830
16. Sanchez-Ramos L., and Kaunitz A.M. Misoprostol for cervical ripening and labor induction: A systematic review of the literature. Clin Obstet Gynecol 43 (2000) 475-488
17. Agency for Healthcare Research Quality Web site. US Department of Health and Human Services. Management of prolonged pregnancy. Summary, Evidence Report/Technology Assessment: Number 53. AHRQ Publication No. 02-E012, March 2002. Available from: www.ahrq.gov/clinic/epcsums/prolongsum.htm [Assessed December 10, 2008].
18. Tanir H.M., Sener T., Yildiz C., Kaya M., and Kurt I. A prospective randomized trial of labor induction with vaginal controlled-release dinoprostone inserts with or without oxytocin and misoprostol + oxytocin. Clin Exp Obstet Gynecol 35 (2008) 65-68
19. Use of approved drugs for unlabeled indications. FDA Bull 12 (1982) 4-5
20. In: Lockwood C., Riley L., Blackmon L., and Lemons J.A. (Eds). Guidelines for perinatal care. 6th ed (2007), American Academy of Pediatrics and American College of Obstetricians and Gynecologists, Elk Grove Village, IL
21. Cheng S.Y., Ming H., and Lee J.C. Titrated oral compared with vaginal misoprostol for labor induction: A randomized controlled trial. Obstet Gynecol 111 (2008) 119-125
22. Muzonzini G., and Hofmeyr G.J. Buccal or sublingual misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev 4 (2004) CD004221
23. Colon I., Clawson K., Hunter K., Druzin M.L., and Taslimi M.M. Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol. Am J Obstet Gynecol 192 (2005) 747-752
24. Castaneda C., Puente J., Ochoa R., Plasse T., Powers B., and Rayburn W. Misoprostol dose selection in a controlled-release vaginal insert for induction of labor in nulliparous women. Am J Obstet Gynecol 193 (2005) 1071-1075
25. Cecatti J.G., Tedesco R.P., Pires H.M., Calderon I.M., and Faúndes A. Effectiveness and safety of a new vaginal misoprostol product specifically labeled for cervical ripening and labor induction. Acta Obstet Gynecol Scand 85 (2006) 706-711